Trial Profile
PHASE I-II STUDY OF F17752 IN PATIENTS WITH ADVANCED SOLID TUMOURS
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 05 Sep 2017
Price :
$35
*
At a glance
- Drugs F 17752 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors Pierre Fabre
- 05 Sep 2017 This trial was discontinued in France (end date: 2013-10-13), according to European Clinical Trials Database.
- 24 Sep 2015 New trial record